Home
Kiniksa

Kiniksa Market Share Analysis for August 2026

kiniksa pharmaceuticals is a biopharmaceutical company that believes every second makes a difference for patients living with debilitating diseases.

Health > Biotechnology and Pharmaceuticals

Domainkiniksa.com

Year Founded2015

Employees201 - 500

Annual Revenue$500M - $1B

Kiniksa

Kiniksa (including company regionals)

kiniksa.com

See more website traffic and engagement information

Kiniksa Revenue up to August 2026 is 500M - 1B

revenue generated by Kiniksa top domains

Kiniksa top domains revenue over 3 years

Revenue for Kiniksa top domains

kiniksa.com500M - 1B

See more with Sales Intelligence

Total visits to Kiniksa's top domains

Understand Kiniksa market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kiniksa.com10.2K

See more with Sales Intelligence

Avg. visit duration in Kiniksa's top domains

Analyze Kiniksa engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kiniksa.com00:00:12

See more with Sales Intelligence

Avg. pageviews on Kiniksa's top domains

See how Kiniksa keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kiniksa.com1.74

See more with Sales Intelligence

Kiniksa top competitors by domain

Top similar sites in August 2026, ranked by their affinity

immunovant.comCompany NameImmunovantEmployees201 - 500HQUnited States, New York, New York CityAnnual revenue$5M - $10MTotal visits5.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Kiniksa

These are the website technologies, by industry, used by Kiniksa top domains

Conversion & Analytics (5)

Google Analytics

Content Management System (4)

WordPress

Widget (4)

Twemoji

Advertising (3)

DoubleClick

More Technologies

11

See all

News & Signals from Kiniksa

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKiniksa Pharmaceuticals, Ltd. will attend event Wells Fargo 21st Annual Healthcare Conference on Sep 9th '26.LONDON, Sept. 04, 2026 (GLOBE NEWSWIRE) - Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026 at 8:45 a.m. Eastern Time.

NewsKiniksa Pharmaceuticals, Ltd. had revenue of $244M on Jul 1st '26.* KNSA recently reported quarterly earnings of $0.30 per share, matching estimates, while revenue of $243.6 million exceeded the $226.49 million consensus forecast.

NewsKiniksa Pharmaceuticals, Ltd. had earnings of $25.4M on Jul 1st '26.Operating expenses grew in line with top-line expansion - driven by increased clinical investment and commercialization - but Kiniksa still achieved a net income of $25.43 million for the quarter.